Avicanna Inc

AVCN

Company Profile

  • Business description

    Avicanna Inc is a commercial-stage international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for the global medical and pharmaceutical market segments. It has three operating segments: Canada, International, and Corporate. It generates the majority of its revenue from Canada.

  • Contact

    480 University Avenue
    Suite 1502
    TorontoBCM5G 1V2
    CAN

    T: +1 647 243-5283

    https://www.avicanna.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    87

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,813.0028.90-0.33%
CAC 407,696.2758.28-0.75%
DAX 4023,787.45146.68-0.61%
Dow JONES (US)44,828.53344.110.77%
FTSE 1008,822.910.29-0.00%
HKSE23,821.5194.55-0.40%
NASDAQ20,601.10207.971.02%
Nikkei 22539,628.41182.47-0.46%
NZX 50 Index12,758.957.65-0.06%
S&P 5006,279.3551.930.83%
S&P/ASX 2008,573.2029.80-0.35%
SSE Composite Index3,465.406.92-0.20%

Market Movers